These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30746695)

  • 21. "The difference that makes a difference": highlighting the role of variable contexts within an HIV Prevention Community Randomised Trial (HPTN 071/PopART) in 21 study communities in Zambia and South Africa.
    Bond V; Chiti B; Hoddinott G; Reynolds L; Schaap A; Simuyaba M; Ndubani R; Viljoen L; Simwinga M; Fidler S; Hayes R; Ayles H; Seeley J;
    AIDS Care; 2016; 28 Suppl 3():99-107. PubMed ID: 27421057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented cross-sectional studies with abbreviated follow-up for estimating HIV incidence.
    Claggett B; Lagakos SW; Wang R
    Biometrics; 2012 Mar; 68(1):62-74. PubMed ID: 21668904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa.
    Todd J; Carpenter L; Li X; Nakiyingi J; Gray R; Hayes R
    Int J Epidemiol; 2003 Oct; 32(5):755-62. PubMed ID: 14559745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simpler tool for estimation of HIV incidence from cross-sectional, age-specific prevalence data.
    Rajan SS; Sokal D
    J Epidemiol Community Health; 2011 Feb; 65(2):111-5. PubMed ID: 20558420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sample size considerations in the design of cluster randomized trials of combination HIV prevention.
    Wang R; Goyal R; Lei Q; Essex M; De Gruttola V
    Clin Trials; 2014 Jun; 11(3):309-318. PubMed ID: 24651566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa.
    Kharsany AB; Cawood C; Khanyile D; Grobler A; Mckinnon LR; Samsunder N; Frohlich JA; Abdool Karim Q; Puren A; Welte A; George G; Govender K; Toledo C; Chipeta Z; Zembe L; Glenshaw MT; Madurai L; Deyde VM; Bere A
    BMC Public Health; 2015 Nov; 15():1149. PubMed ID: 26588902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixture models for calibrating the BED for HIV incidence testing.
    Mahiane SG; Fiamma A; Auvert B
    Stat Med; 2014 May; 33(10):1767-83. PubMed ID: 24834521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methods.
    Bautista-Arredondo S; Sosa-Rubí SG; Opuni M; Kwan A; Chaumont C; Coetzee J; Condo J; Dzekedzeke K; Galárraga O; Martinson N; Masiye F; Nsanzimana S; Wamai R; Wang'ombe J;
    BMC Health Serv Res; 2014 Nov; 14():599. PubMed ID: 25927555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Person-time analysis of paired community intervention trials when the number of communities is small.
    Brookmeyer R; Chen YQ
    Stat Med; 1998 Sep; 17(18):2121-32. PubMed ID: 9789918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatial clustering of "measured" and "unmeasured" risk factors for HIV infections in hyper-endemic communities in KwaZulu-Natal, South Africa: results from geoadditive models.
    Wand H; Ramjee G
    AIDS Care; 2015; 27(11):1375-81. PubMed ID: 26679265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional HIV incidence estimation in an evolving epidemic.
    Morrison D; Laeyendecker O; Brookmeyer R
    Stat Med; 2019 Aug; 38(19):3614-3627. PubMed ID: 31115081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting HIV services to male migrant workers in southern Africa would not reverse generalized HIV epidemics in their home communities: a mathematical modeling analysis.
    Klein DJ; Eckhoff PA; Bershteyn A
    Int Health; 2015 Mar; 7(2):107-13. PubMed ID: 25733560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A seroepidemiological study of human immunodeficiency virus infection in northeast Zaire.
    Bernal MC; Galán MI; Ocete MD; Leyva A; García F; García-Valdecasas J; Maroto MC; Piédrola G
    Infection; 1994; 22(3):174-7. PubMed ID: 7927812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing.
    Bärnighausen T; Wallrauch C; Welte A; McWalter TA; Mbizana N; Viljoen J; Graham N; Tanser F; Puren A; Newell ML
    PLoS One; 2008; 3(11):e3640. PubMed ID: 18982059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing HIV prevalence in a rural district of South Africa from 1992 through 1995.
    Coleman RL; Wilkinson D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):50-3. PubMed ID: 9377125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening surgeons for HIV infection: assessment of a potential public health program.
    Schulman KA; McDonald RC; Lynn LA; Frank I; Christakis NA; Schwartz JS
    Infect Control Hosp Epidemiol; 1994 Mar; 15(3):147-55. PubMed ID: 8207171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine screening for hepatitis C viral infection in patients undergoing elective cranial neurosurgery.
    Nussbaum ES; Kallmes K; Lowary J; Nussbaum LA
    J Neurosurg; 2018 Sep; 131(3):941-948. PubMed ID: 30215562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.